Signposting evidence-based information on the treatment of hypertension in pregnancy

Condition management

It is important to complete an individual risk assessment for your patient and to apply the principles of prescribing during pregnancy when looking at the available information and making treatment decisions. Check to see if a risk assessment has already been completed by the specialist team.

Untreated or inadequately treated hypertension can have adverse effects on the mother and therefore on the foetus.


NICE Guideline [NG133] and CKS provide good guidance and information on the management of hypertension in pregnancy. This includes information on:

NICE Clinical guideline [NG133] has a useful interactive flowchart for the diagnosis and management of hypertension in pregnancy including treatment options for chronic and gestational hypertension and pre-eclampsia.

You should check if there is local guidance for you to use in your area.

Pregnancy outcome information

UK Teratology Information Service (UKTIS) provides more detailed information on pregnancy outcomes for the common antihypertensive medicines. They also have overviews on the use of beta-blockerscalcium channel blockers and angiotensin converting enzyme (ACE) inhibitors in pregnancy.

Patient information

Each of the UKTIS summaries has corresponding Best Use of Medicine in Pregnancy (BUMPS) patient information.

The Royal College of Obstetricians and Gynaecologists (RCOG) provides patient information on pre-eclampsia

The NHS website provides an overview of high blood pressure (hypertension) and pregnancy (including pre-eclampsia) and a summary statement on the use in pregnancy of specific antihypertensive medicines.

Support for prescribing decisions in people on interacting medicines, those with swallowing difficulties, renal impairment, or who are pregnant or breastfeeding
SPS protocol templates for the supply and administration of omeprazole for pre planned caesarean section by registered midwives.
SPS PGD template for administering subcutaneous terbutaline sulfate for the reduction of contraction frequency in individuals in labour.
SPS PGD template for the intrapartum administration of benzylpenicillin for prevention of early-onset Group B Streptococcus (GBS) infection in neonates.
Opioid analgesics may be used at any stage of pregnancy at the lowest effective dose for the short-term relief of pain when other analgesics are not effective.
Intramuscular hydroxocobalamin is the preferred treatment choice for management of clinically relevant vitamin B12 deficiency, including during pregnancy.
SPS PGD template for the supply of folic acid 5mg tablets to reduce risk of neural tube defect or compensate for increased folate demand during pregnancy.
SPS PGD template for the supply of aspirin tablets to individuals at risk of pre-eclampsia during pregnancy.
Signposting evidence-based information on the treatment of pain in pregnancy
Signposting evidence-based information on the treatment of urinary tract infection in pregnancy

Print this page